Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling

Marc S Raab1, Iris Breitkreutz, Giovanni Tonon

  • 1LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. marc_raab@dfci.harvard.edu

Blood
|November 20, 2008
PubMed

Insights

Enzastaurin inhibits protein kinase C (PKC) in multiple myeloma, causing beta-catenin accumulation. This triggers endoplasmic reticulum stress and apoptosis, revealing p73 as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Protein kinase C (PKC) inhibitors, like enzastaurin, show preclinical anti-cancer activity.
  • The precise mechanisms of enzastaurin in multiple myeloma (MM) require further elucidation.
  • Beta-catenin's role in cancer cell growth and survival is complex and context-dependent.

Purpose of the Study:

  • To investigate the mechanism of action of enzastaurin in multiple myeloma cells.
  • To identify the role of beta-catenin in mediating enzastaurin's effects.
  • To explore novel therapeutic targets in multiple myeloma based on enzastaurin's action.

Main Methods:

  • Treatment of multiple myeloma cells with enzastaurin.
  • Analysis of beta-catenin accumulation and phosphorylation.
  • Microarray analysis and siRNA-mediated gene silencing to assess signaling pathways.
  • Investigation of downstream targets including eIF2alpha, CHOP, p21, c-Jun, and p73.

Main Results:

  • Enzastaurin inhibits PKC, leading to beta-catenin accumulation by preventing its degradation.
  • Accumulated beta-catenin induces endoplasmic reticulum (ER) stress via eIF2alpha, CHOP, and p21, causing growth inhibition.
  • Beta-catenin accumulation triggers c-Jun-dependent induction of p73, promoting apoptosis in MM cells.
  • p73 is identified as a key mediator of enzastaurin-induced apoptosis.

Conclusions:

  • Beta-catenin plays a novel role in ER stress-mediated growth inhibition and apoptosis induction upon PKC inhibition.
  • Enzastaurin induces MM cell death through a novel beta-catenin/c-Jun/p73 apoptotic pathway.
  • p73 represents a potential novel therapeutic target for multiple myeloma treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...